{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:46:20Z","timestamp":1787805980236,"version":"build-2784847793"},"reference-count":115,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The suprachoroidal space (SCS), a potential space between the sclera and choroid, is becoming an applicable method to deliver therapeutics to the back of the eye. In recent years, a vast amount of research in the field has been carried out, with new discoveries in different areas of interest, such as imaging, drug delivery methods, pharmacokinetics, pharmacotherapies in preclinical and clinical trials and advanced therapies. The SCS can be visualized via advanced techniques of optical coherence tomography (OCT) in eyes with different pathologies, and even in healthy eyes. Drugs can be delivered easily and safely via hollow microneedles fitted to the length of the approximate thickness of the sclera. SCS injections were found to reach greater baseline concentrations in the target layers compared to intravitreal (IVT) injection, while agent clearance was faster with highly aqueous soluble molecules. Clinical trials with SCS injection of triamcinolone acetonide (TA) were executed with promising findings for patients with noninfectious uveitis (NIU), NIU implicated with macular edema and diabetic macular edema (DME). Gene therapy is evolving rapidly with viral and non-viral vectors that were found to be safe and efficient in preclinical trials. Here, we review these novel different aspects and new developments in clinical treatment of the posterior segment of the eye.<\/jats:p>","DOI":"10.3390\/pharmaceutics13070967","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T23:57:22Z","timestamp":1624838242000},"page":"967","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases"],"prefix":"10.3390","volume":"13","author":[{"given":"Liron","family":"Naftali Ben Haim","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Meir Medical Center, Kfar Saba, 59 Tshernichovsky St., Kfar Saba 4428164, Israel"},{"name":"The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Moisseiev","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Meir Medical Center, Kfar Saba, 59 Tshernichovsky St., Kfar Saba 4428164, Israel"},{"name":"The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clindermatol.2014.10.006","article-title":"Human ocular anatomy","volume":"33","author":"Kels","year":"2015","journal-title":"Clin. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/APO.0000000000000146","article-title":"Intravitreal injection-technique and safety","volume":"4","author":"Lai","year":"2015","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15171\/bi.2016.07","article-title":"Advanced drug delivery and targeting technologies for the ocular diseases","volume":"6","author":"Barar","year":"2016","journal-title":"BioImpacts"},{"key":"ref_5","first-page":"1","article-title":"Ocular drug delivery to the retina: Current innovations and future perspectives","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems. A shift to the posterior segment","volume":"13","author":"Urtti","year":"2008","journal-title":"Drug Discov. Today"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Heikkinen","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_8","first-page":"233","article-title":"Hydrostatic Pressure of the Suprachoroidal space","volume":"30","author":"Emi","year":"1989","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1034\/j.1600-0420.1998.760502.x","article-title":"Light microscopy of uveoscleral drainage routes after gelatine injections into the suprachoroidal space","volume":"76","author":"Krohn","year":"1998","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0420.1997.tb00245.x","article-title":"Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the human eye","volume":"75","author":"Krohn","year":"1997","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11095-010-0271-y","article-title":"Suprachoroidal drug delivery to the back of the eye using hollow microneedles","volume":"28","author":"Patel","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1167\/iovs.12-9872","article-title":"Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye","volume":"53","author":"Patel","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.exer.2016.03.008","article-title":"Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries","volume":"145","author":"Chiang","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/OPTH.S89784","article-title":"The suprachoroidal space: From potential space to a space with potential","volume":"10","author":"Moisseiev","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0039-6257(88)90093-8","article-title":"Posterior scleritis","volume":"32","author":"Benson","year":"1988","journal-title":"Surv. Ophthalmol."},{"key":"ref_16","first-page":"94","article-title":"Past, present, and future concepts of the choroidal scleral interface morphology on optical coherence tomography","volume":"6","author":"Huynh","year":"2017","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_17","first-page":"42","article-title":"Retinal Physician\u2014Going Deeper and Wider","volume":"10","author":"Michalewska","year":"2013","journal-title":"Retin. Physician"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","article-title":"Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography","volume":"146","author":"Spaide","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.35119\/asjoo.v16i4.434","article-title":"Optimized imaging of the suprachoroidal space with swept-source OCT","volume":"16","author":"Hanhart","year":"2019","journal-title":"Asian J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1167\/iovs.10-6024","article-title":"Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography","volume":"52","author":"Rahman","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamaophthalmol.2013.7288","article-title":"Characterization of the choroid-scleral junction and suprachoroidal layer in healthy individuals on enhanced-depth imaging optical coherence tomography","volume":"132","author":"Yiu","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/IAE.0000000000000281","article-title":"Suprachoroidal layer and suprachoroidal space delineating the outer margin of the choroid in swept-source optical coherence tomography","volume":"35","author":"Michalewska","year":"2015","journal-title":"Retina"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/IIO.0000000000000251","article-title":"Medical and surgical applications for the suprachoroidal space","volume":"59","author":"Yiu","year":"2019","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/02713683.2015.1056374","article-title":"Imaging Suprachoroidal Layer in Exudative Age-Related Macular Degeneration","volume":"41","author":"Kim","year":"2016","journal-title":"Curr. Eye Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajo.2015.08.018","article-title":"Loculation of Fluid in the Posterior Choroid in Eyes with Central Serous Chorioretinopathy","volume":"160","author":"Spaide","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1167\/iovs.16-20070","article-title":"Effect of uveal melanocytes on choroidal morphology in rhesus macaques and humans on enhanced-depth imaging optical coherence tomography","volume":"57","author":"Yiu","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Peden, M.C., Min, J., Meyers, C., Lukowski, Z., Li, Q., Boye, S.L., Levine, M., Hauswirth, W.W., Ratnakaram, R., and Dawson, W. (2011). Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017140"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ajo.2006.05.045","article-title":"Cannulation of the Suprachoroidal Space: A Novel Drug Delivery Methodology to the Posterior Segment","volume":"142","author":"Olsen","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_29","first-page":"1533","article-title":"Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye","volume":"43","author":"Einmahl","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.exer.2013.10.023","article-title":"Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy","volume":"118","author":"Tzameret","year":"2014","journal-title":"Exp. Eye Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/IAE.0b013e3182576d1d","article-title":"Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits","volume":"32","author":"Wang","year":"2012","journal-title":"Retina"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1167\/iovs.06-0670","article-title":"Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging","volume":"48","author":"Kim","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1167\/iovs.10-6291","article-title":"Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model","volume":"52","author":"Olsen","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2147\/OPTH.S57217","article-title":"A review of the iStent\u00ae trabecular micro-bypass stent: Safety and efficacy","volume":"9","author":"Wellik","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"ref_35","first-page":"875","article-title":"Prospective unmasked randomized evaluation of the iStent inject\u00ae versus two ocular hypotensive agents in patients with primary open-angle glaucoma","volume":"8","author":"Fea","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/IJG.0000000000000134","article-title":"Initial clinical experience with the Cy pass micro-stent: Safety and surgical outcomes of a novel supraciliary microstent","volume":"25","author":"Hoeh","year":"2016","journal-title":"J. Glaucoma"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2015.02.021","article-title":"Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model","volume":"203","author":"Chen","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/mp300716t","article-title":"Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab","volume":"10","author":"Tyagi","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.scr.2015.08.007","article-title":"Epiretinal transplantation of human bone marrow mesenchymal stem cells rescues retinal and vision function in a rat model of retinal degeneration","volume":"15","author":"Tzameret","year":"2015","journal-title":"Stem Cell Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hancock, S.E., Wan, C.R., Fisher, N.E., Andino, R.V., and Ciulla, T.A. Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies. Expert Opin. Drug Deliv., 2021.","DOI":"10.1080\/17425247.2021.1867532"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: A smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s13346-016-0332-9","article-title":"Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery","volume":"6","author":"Thakur","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","article-title":"Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study","volume":"2","author":"Campochiaro","year":"2018","journal-title":"Ophthalmol. Retin."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.03.001","article-title":"The suprachoroidal space as a route of administration to the posterior segment of the eye","volume":"126","author":"Chiang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3928\/23258160-20180831-07","article-title":"Suprachoroidal space alterations following delivery of triamcinolone acetonide: Post-hoc analysis of the phase 1\/2 HULK study of patients with diabetic macular edema","volume":"49","author":"Lampen","year":"2018","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_47","first-page":"4954","article-title":"Post Hoc Analysis of Clinical Suprachoroidal Injection Experience Across Retinal Disease Indications","volume":"61","author":"Wan","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1351\/pac200476051033","article-title":"Glossary of terms used in toxicokinetics (IUPAC Recommendations 2003)","volume":"76","author":"Nordberg","year":"2004","journal-title":"Pure Appl. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tyagi, P., Kadam, R.S., and Kompella, U.B. (2012). Comparison of Suprachoroidal Drug Delivery with Subconjunctival and Intravitreal Routes Using Noninvasive Fluorophotometry. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048188"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1167\/iovs.15-16597","article-title":"Real-time monitoring of suprachoroidal space (SCS) following SCS injection using ultra-high resolution optical coherence tomography in guinea pig eyes","volume":"56","author":"Gu","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/jop.2013.0063","article-title":"Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model","volume":"29","author":"Abarca","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejpb.2015.05.020","article-title":"Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles","volume":"95","author":"Kim","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1167\/iovs.16-20377","article-title":"Thickness and closure kinetics of the suprachoroidal space following microneedle injection of liquid formulations","volume":"58","author":"Chiang","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.exer.2016.10.011","article-title":"Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection","volume":"153","author":"Chiang","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1167\/iovs.11-7525","article-title":"Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes","volume":"52","author":"Seiler","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.drudis.2019.03.027","article-title":"Targeting drug delivery within the suprachoroidal space","volume":"24","author":"Jung","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Jung, J.H., Park, S., Chae, J.J., and Prausnitz, M.R. (2019). Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targeting. Exp. Eye Res., 189.","DOI":"10.1016\/j.exer.2019.107824"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3797\/scipharm.1108-20","article-title":"Iontophoresis: A Potential Emergence of a Transdermal Drug Delivery System","volume":"80","author":"Dhote","year":"2012","journal-title":"Sci. Pharm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2018.03.001","article-title":"Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle","volume":"277","author":"Jung","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jare.2013.07.006","article-title":"Hydrogel: Preparation, characterization, and applications: A review","volume":"6","author":"Ahmed","year":"2015","journal-title":"J. Adv. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Burdick, J.A., and Prestwich, G.D. (2011). Hyaluronic acid hydrogels for biomedical applications. Adv. Mater., 23.","DOI":"10.1002\/adma.201003963"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1167\/iovs.17-23758","article-title":"Targeted drug delivery in the suprachoroidal space by swollen hydrogel pushing","volume":"59","author":"Jung","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/adhm.201300696","article-title":"Particle-Stabilized Emulsion Droplets for Gravity-Mediated Targeting in the Posterior Segment of the Eye","volume":"3","author":"Kim","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"ref_64","first-page":"3694","article-title":"Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits","volume":"61","author":"Hancock","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1167\/iovs.16-20679","article-title":"Clearance kinetics and clearance routes of molecules from the suprachoroidal space after microneedle injection","volume":"58","author":"Chiang","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/09205063.2012.745714","article-title":"Evaluation of RGD peptide hydrogel in the posterior segment of the rabbit eye","volume":"24","author":"Wang","year":"2013","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jbm.a.10597","article-title":"Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation","volume":"67","author":"Einmahl","year":"2003","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1463-5224.2010.00807.x","article-title":"Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis","volume":"13","author":"Gilger","year":"2010","journal-title":"Vet. Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1167\/iovs.05-1540","article-title":"A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis","volume":"47","author":"Gilger","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Prieto, E., Cardiel, M.J., Vispe, E., Idoipe, M., Garcia-Martin, E., Fraile, J.M., Polo, V., Mayoral, J.A., Pablo, L.E., and Rodrigo, M.J. (2020). Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation. Biomed. Mater., 15.","DOI":"10.1088\/1748-605X\/aba445"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1167\/iovs.15-18127","article-title":"Anti-inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats","volume":"57","author":"Saliba","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hackett, S.F., Fu, J., Kim, Y.C., Tsujinaka, H., Shen, J., Lima e Silva, R., Khan, M., Hafiz, Z., Wang, T., and Shin, M. (2020). Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization. Biomaterials, 243.","DOI":"10.1016\/j.biomaterials.2020.119935"},{"key":"ref_73","first-page":"5259.","article-title":"Intraocular Distribution and Targeting of Triamcinolone Acetonide Suspension Administered Into the Suprachoroidal Space","volume":"55","author":"Edelhauser","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1167\/iovs.13-11747","article-title":"Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles","volume":"54","author":"Gilger","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_75","first-page":"60","article-title":"Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study","volume":"5","author":"Barakat","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Khurana, R.N., Merrill, P., Yeh, S., Suhler, E., Barakat, M.R., Uchiyama, E., Henry, C.R., Shah, M., Wang, R.C., and Kapik, B. (2021). Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). Br. J. Ophthalmol., 1\u20136.","DOI":"10.1136\/bjophthalmol-2020-317560"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Henry, C.R., Shah, M., Barakat, M.R., Dayani, P., Wang, R.C., Khurana, R.N., Rifkin, L., Yeh, S., Hall, C., and Ciulla, T. (2021). Suprachoroidal CLS-TA for non-infectious uveitis: An open-label, safety trial (AZALEA). Br. J. Ophthalmol., 1\u20135.","DOI":"10.1136\/bjophthalmol-2020-318019"},{"key":"ref_78","unstructured":"(2021, April 07). Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO (SAPPHIRE). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02980874."},{"key":"ref_79","unstructured":"(2021, April 07). Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO (TOPAZ). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03203447."},{"key":"ref_80","first-page":"4925","article-title":"Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension) in rabbits","volume":"61","author":"Muya","year":"2020","journal-title":"iOVS"},{"key":"ref_81","unstructured":"(2021, April 26). Clearside Biomedical Announces First Patients Enrolled in Phase 1\/2a Clinical Trial of CLS-AX (Axitinib Injectable Suspension) for the Treatment of Wet AMD. Available online: https:\/\/ir.clearsidebio.com\/news-releases\/news-release-details\/clearside-biomedical-announces-first-patients-enrolled-phase-12a."},{"key":"ref_82","unstructured":"(2021, April 26). Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD (OASIS). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04626128?intr=Suprachoroidal+Injection&draw=2&rank=12."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1172\/JCI129085","article-title":"AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression","volume":"129","author":"Ding","year":"2019","journal-title":"J. Clin. Invest."},{"key":"ref_84","unstructured":"(2021, April 26). RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04514653?intr=Suprachoroidal+Injection&draw=2&rank=15."},{"key":"ref_85","unstructured":"(2021, April 26). Aura Biosciences Announces Dosing of First Patient in Phase 2 Study Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma. Available online: http:\/\/www.aurabiosciences.com\/news-archive\/2020\/6\/12\/aura-biosciences-presents-updated-au-011-clinical-data-at-arvo-2020-njm82."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/jop.2019.0126","article-title":"Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases","volume":"36","author":"Kansara","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2017.02.018","article-title":"Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial","volume":"177","author":"Constable","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14712598.2018.1389886","article-title":"Gene therapy for inherited retinal and optic nerve degenerations","volume":"18","author":"Moore","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_89","unstructured":"(2021, April 26). Gene Therapy: The Next Frontier for Treatment of Acquired and Inherited Ocular Disorders. Available online: http:\/\/fyra.io."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"ref_91","first-page":"1931","article-title":"Comparison of Suprachoroidal delivery via an Ab-Externo approach with the iTrack Microcatheter versus Vitrectomy and subretinal delivery for 3 different AAV Serotypes for Gene Transfer to the Retina","volume":"53","author":"Martorana","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/S1525-0016(16)33352-4","article-title":"544. Comparison of AAV Serotype2 Transduction by Various Delivery Routes to the Mouse Eye","volume":"24","author":"Woodard","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Ding, K., Shen, J., Hackett, S., Khan, M., and Campochiaro, P.A. (2021). Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina. Gene Ther.","DOI":"10.1038\/s41434-021-00233-1"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Chung, S.H., Mollhoff, I.N., Mishra, A., Sin, T., Ngo, T., Ciulla, T., Sieving, P.A., Thomasy, S., and Yiu, G. (2021). Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes. Hum. Gene Ther.","DOI":"10.1101\/2020.09.25.313676"},{"key":"ref_96","first-page":"293","article-title":"Advances in gene delivery systems","volume":"25","author":"Kamimura","year":"2011","journal-title":"Pharmaceut. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/sj.gt.3302367","article-title":"DNA electrotransfer: Its principles and an updated review of its therapeutic applications","volume":"11","author":"Mir","year":"2004","journal-title":"Gene Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/mt.2011.304","article-title":"Suprachoroidal electrotransfer: A nonviral gene delivery method to transfect the choroid and the retina without detaching the retina","volume":"20","author":"Touchard","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Santos, A., Altamirano-Vallejo, J.C., Navarro-Partida, J., la Rosa, A.G.-D., and Hsiao, J.H. (2020). Breaking down the Barrier: Topical Liposomes as Nanocarriers for Drug Delivery into the Posterior Segment of the Eyeball. Role of Novel Drug Delivery Vehicles in Nanobiomedicine, IntechOpen.","DOI":"10.5772\/intechopen.86601"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.gt.3302475","article-title":"Nonviral ocular gene transfer","volume":"12","author":"Kachi","year":"2005","journal-title":"Gene Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.18240\/ijo.2019.08.06","article-title":"Dynamic changes of activator protein 1 and collagen i expression in the sclera of myopia Guinea pigs","volume":"12","author":"Zhan","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/ar7002336","article-title":"A combinatorial polymer library approach yields insight into nonviral gene delivery","volume":"41","author":"Green","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.9.13.21","article-title":"Suprachoroidally delivered dna nanoparticles transfect retina and retinal pigment epithelium\/choroid in rabbits","volume":"9","author":"Kansara","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Shen, J., Kim, J., Tzen, S.Y., Ding, K., Hafiz, Z., Long, D., Wang, J., Gree, J.J., and Campochia, P.A. (2020). Suprachoroidal gene transfer with nonviral nanoparticles. Sci. Adv., 6.","DOI":"10.1126\/sciadv.aba1606"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-62703-751-8_16","article-title":"Molecular targeted viral nanoparticles as tools for imaging cancer","volume":"1108","author":"Cho","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/mp100225y","article-title":"The art of engineering viral nanoparticles","volume":"8","author":"Pokorski","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_107","first-page":"3615","article-title":"Ocular distribution and efficacy after suprachoroidal injection of AU-011 for treatment of ocular melanoma","volume":"61","author":"Savinainen","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1874467208666150928153511","article-title":"Stem Cell Therapy and Immunological Rejection in Animal Models","volume":"9","author":"Jin","year":"2015","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_109","first-page":"250","article-title":"Regenerative therapy for retinal disorders","volume":"5","author":"Daftarian","year":"2010","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1018987108","article-title":"Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"46913","DOI":"10.18632\/oncotarget.10442","article-title":"Cell surgery and growth factors in dry age-related macular degeneration: Visual prognosis and morphological study","volume":"7","author":"Limoli","year":"2016","journal-title":"Oncotarget"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Limoli, P.G., Vingolo, E.M., Limoli, C., Scalinci, S.Z., and Nebbioso, M. (2018). Regenerative therapy by suprachoroidal cell autograft in dry age-related macular degeneration: Preliminary in vivo report. J. Vis. Exp., 2018.","DOI":"10.3791\/56469"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Kahraman, N.S., and \u00d6ner, A. (2020). Umbilical cord-derived mesenchymal stem cell implantation in patients with optic atrophy. Eur. J. Ophthalmol.","DOI":"10.1177\/1120672120977824"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s10792-019-01141-5","article-title":"Six-month results of suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with optic atrophy: A phase 1\/2 study","volume":"39","author":"Oner","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/cell.2018.0045","article-title":"Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and stargardt\u2019s macular dystrophy: 6-month follow-up results of a phase 2 study","volume":"20","author":"Oner","year":"2018","journal-title":"Cell. Reprogram."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/7\/967\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:24:55Z","timestamp":1760163895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/7\/967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":115,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["pharmaceutics13070967"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13070967","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]}}}